The Claim
In men with gout and preserved kidney function, a low fractional excretion of uric acid (FEUA ≤5.5%) is associated with higher plasma concentrations of oxypurinol, indicating that renal tubular reabsorption mechanisms shared with urate also govern oxypurinol clearance.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In men with gout and normal kidney function, lower urinary excretion of uric acid correlates with higher blood levels of oxypurinol, suggesting that the same kidney processes that reabsorb uric acid also reabsorb oxypurinol.
See the scientific wording
In men with gout and preserved kidney function, low fractional excretion of uric acid (FEUA ≤5.5%) is associated with higher plasma concentrations of oxypurinol, the active metabolite of allopurinol, suggesting that renal tubular reabsorption mechanisms shared with urate also govern oxypurinol clearance.
When the kidneys reabsorb more uric acid, they also reabsorb the active part of allopurinol, called oxypurinol, using the same transporters. This causes oxypurinol to stay in the blood longer and at higher levels, which makes it better at blocking uric acid production.
What the research says
1 studyIn men with gout and healthy kidneys, those whose kidneys hold onto more uric acid also have more of the active part of allopurinol in their blood—because their kidneys treat both substances the same way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.